Penicillins, cephalosporins, fluoroquinolones, aminoglycosides, and glycopeptides — including beta-lactamase inhibitor combinations — for bacterial infection management. Supplied in USP/EP/BP grade for oral and sterile injectable formulation manufacturing.
Beta-lactamase-resistant penicillin supplied as sodium salt monohydrate — the standard trading form, USP/EP/BP grade — for oral capsule and suspension formulation manufacturing.
USPEPBP
Oral
CAS 24390-14-5 (hyclate)Product Code AB-022WHO-GMP
Doxycycline
Broad-spectrum tetracycline supplied as hyclate salt — the standard trading form, USP/BP grade — for oral tablet, capsule, and injectable formulation manufacturing.
USPBP
Oral
Injection
CAS 93106-60-6Product Code AB-024WHO-GMP
Enrofloxacin
Fluoroquinolone for veterinary injectable and oral suspension formulation manufacturing. Note: veterinary-only — not approved for human therapeutic use in most markets.
Oral
Injection
CAS 106560-14-9 (base) / 122547-49-3 (sodium)Product Code AB-023WHO-GMP
Faropenem
Orally-active penem-class beta-lactam, available as free base and sodium salt, for tablet formulation manufacturing — broad-spectrum coverage including beta-lactamase-producing organisms.
Oral
CAS 112811-59-3Product Code AB-025WHO-GMP
Gatifloxacin
Fourth-generation fluoroquinolone in pharmaceutical grade for oral tablet and ophthalmic solution formulation manufacturing.
Oral
Ophthalmic
CAS fixed 1:1 ratioProduct Code AB-026WHO-GMP
Imipenem with Cilastatin
Carbapenem antibiotic co-formulated 1:1 with the dehydropeptidase inhibitor cilastatin, which is mandatory (not optional) to prevent renal degradation, for sterile injectable formulation manufacturing.
Injection
CAS 138199-71-0 (hemihydrate)Product Code AB-027WHO-GMP
Levofloxacin
Third-generation fluoroquinolone, the S-enantiomer of ofloxacin, supplied as hemihydrate — USP/BP grade — for oral tablet and injectable formulation manufacturing.
USPBP
Oral
Injection
CAS 186826-86-8 (HCl)Product Code AB-028WHO-GMP
Moxifloxacin
Fourth-generation fluoroquinolone supplied as hydrochloride salt for oral tablet, injectable, and ophthalmic solution formulation manufacturing.
Oral
Injection
Ophthalmic
CAS 12650-69-0Product Code AB-029WHO-GMP
Mupirocin
Pseudomonic acid topical antibiotic in USP/BP/EP/IP grade for ointment and cream formulation manufacturing, primarily for MRSA nasal decolonisation.
USPBPEPIP
Topical
Nasal
CAS 1405-10-3Product Code AB-030WHO-GMP
Neomycin Sulphate
Aminoglycoside sulfate salt in USP/EP/BP grade for oral tablet, topical, and combination formulation manufacturing — not used systemically due to nephro/ototoxicity.
USPEPBP
Oral
Topical
CAS 82419-36-1Product Code AB-031WHO-GMP
Ofloxacin
Second-generation racemic fluoroquinolone in USP/BP grade for oral tablet, injectable, and ophthalmic solution formulation manufacturing.
USPBP
Oral
Injection
Ophthalmic
CAS fixed 8:1 ratioProduct Code AB-032WHO-GMP
Piperacillin with Tazobactam
Extended-spectrum penicillin/beta-lactamase inhibitor combination at the fixed pharmacopoeial 8:1 ratio for sterile injectable formulation manufacturing.
Injection
CAS 110871-86-8Product Code AB-033WHO-GMP
Sparfloxacin
Third-generation fluoroquinolone in pharmaceutical grade for oral tablet formulation manufacturing. Note: restricted or withdrawn in the US/EU due to phototoxicity and cardiotoxicity concerns.
Oral
CAS 8025-81-8Product Code AB-034WHO-GMP
Spiramycin
16-membered macrolide antibiotic mixture (components I/II/III) in pharmaceutical grade for oral tablet and suspension formulation manufacturing.
Glycopeptide antibiotic complex (multiple A2 components) in EP grade for sterile injectable formulation manufacturing, used as a vancomycin alternative for resistant gram-positive infections.
EP
Injection
CAS 738-70-5Product Code AB-037WHO-GMP
Trimethoprim
Dihydrofolate reductase inhibitor in pharmaceutical grade for oral tablet formulation manufacturing, typically co-formulated with sulfonamides for urinary tract infection treatment.
Oral
CAS 1404-93-9Product Code AB-038WHO-GMP
Vancomycin HCl
Glycopeptide antibiotic supplied as hydrochloride salt — the standard trading form, EP grade — for sterile IV injectable and oral formulation manufacturing against MRSA and C. difficile infections.
